These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
10. Topical ofloxacin in the treatment of Pseudomonas keratitis in a rabbit model. Gritz DC; McDonnell PJ; Lee TY; Tang-Liu D; Hubbard BB; Gwon A Cornea; 1992 Mar; 11(2):143-7. PubMed ID: 1582217 [TBL] [Abstract][Full Text] [Related]
11. The effect of topical ceftazidime on pseudomonas keratitis in rabbits. Kremer I; Robinson A; Braffman M; Drucker M; Goldenfeld M; Samra Z; Myszne-Daye N; Gaton D; Savir H Cornea; 1994 Jul; 13(4):360-3. PubMed ID: 7924338 [TBL] [Abstract][Full Text] [Related]
12. Comparison of topical ciprofloxacin to conventional antibiotic therapy in the treatment of experimental Pseudomonas aeruginosa keratitis. Guzek JP; Chacko D; Kettering JD; Wessels IF; Aprecio RM Cornea; 1994 Nov; 13(6):500-4. PubMed ID: 7842708 [TBL] [Abstract][Full Text] [Related]
13. A laboratory evaluation of antibiotic therapy for ciprofloxacin-resistant Pseudomonas aeruginosa. Rhee MK; Kowalski RP; Romanowski EG; Mah FS; Ritterband DC; Gordon YJ Am J Ophthalmol; 2004 Aug; 138(2):226-30. PubMed ID: 15289131 [TBL] [Abstract][Full Text] [Related]
14. Effectiveness of a new tobramycin (0.3%) and dexamethasone (0.05%) formulation in the treatment of experimental Pseudomonas keratitis. McCormick C; Caballero A; Tang A; Balzli C; Song J; O'Callaghan R Curr Med Res Opin; 2008 Jun; 24(6):1569-75. PubMed ID: 18423106 [TBL] [Abstract][Full Text] [Related]
15. The effectiveness of an improved combination therapy for experimental Staphylococcus aureus keratitis. Balzli CL; McCormick CC; Caballero AR; Tang A; O'Callaghan RJ Adv Ther; 2010 Dec; 27(12):933-40. PubMed ID: 21046494 [TBL] [Abstract][Full Text] [Related]
16. Pharmacokinetic considerations in the treatment of bacterial keratitis. Callegan MC; O'Callaghan RJ; Hill JM Clin Pharmacokinet; 1994 Aug; 27(2):129-49. PubMed ID: 7955776 [TBL] [Abstract][Full Text] [Related]
17. Evaluation of corneal collagen shields as a drug delivery device for the treatment of experimental Pseudomonas keratitis. Silbiger J; Stern GA Ophthalmology; 1992 Jun; 99(6):889-92. PubMed ID: 1630778 [TBL] [Abstract][Full Text] [Related]
18. Topical anti-inflammatory agents in an animal model of microbial keratitis. Gritz DC; Lee TY; Kwitko S; McDonnell PJ Arch Ophthalmol; 1990 Jul; 108(7):1001-5. PubMed ID: 2369336 [TBL] [Abstract][Full Text] [Related]
19. Anti-inflammatory therapy and outcome in a guinea pig model of Pseudomonas keratitis. Ohadi C; Litwin KL; Moreira H; Kwitko S; Gauderman WJ; Gritz DC; Gwon A; Jones R; McDonnell PJ Cornea; 1992 Sep; 11(5):398-403. PubMed ID: 1424667 [TBL] [Abstract][Full Text] [Related]
20. Effect of nitric oxide synthase inhibition in experimental Pseudomonas keratitis in rabbits. Er H; Turkoz Y; Ozerol IH; Uzmez E Eur J Ophthalmol; 1998; 8(3):137-41. PubMed ID: 9793765 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]